应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JUNS Jupiter Neurosciences
未开盘 11-13 16:00:00 EST
1.76
-0.10
-5.38%
盘后
1.76
+0.00
0.00%
19:30 EST
最高
1.90
最低
1.76
成交量
1.26万
今开
1.86
昨收
1.86
日振幅
7.53%
总市值
232.06万
流通市值
193.37万
总股本
131.85万
成交额
2.31万
换手率
1.14%
流通股本
109.87万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
灰度研报:5 大热门代币收益率为负,稀释危机显现
同花顺 · 10-23
灰度研报:5 大热门代币收益率为负,稀释危机显现
海外机构调研股出炉,融资客加仓多只海外机构调研个股(名单)
同花顺 · 09-25
海外机构调研股出炉,融资客加仓多只海外机构调研个股(名单)
Jupiter Neurosciences (纳斯达克: JUNS) 签署最终协议,以最高1亿美元交易价值获得Ala-002美国独家权益
美股速递 · 07-21
Jupiter Neurosciences (纳斯达克: JUNS) 签署最终协议,以最高1亿美元交易价值获得Ala-002美国独家权益
Pharmala Biotech达成价值高达1亿美元协议,包含333万美元预付款及里程碑付款与特许权使用费
美股速递 · 07-21
Pharmala Biotech达成价值高达1亿美元协议,包含333万美元预付款及里程碑付款与特许权使用费
Pharmala Biotech签署最终授权协议,授予Jupiter Neurosciences Ala-002在美国的独家权益
美股速递 · 07-21
Pharmala Biotech签署最终授权协议,授予Jupiter Neurosciences Ala-002在美国的独家权益
SK Pharmteco宣布与孤儿药加速器达成战略合作
投资观察 · 06-18
SK Pharmteco宣布与孤儿药加速器达成战略合作
Jupiter Neurosciences宣布帕金森病二期a阶段Reset试验患者招募启动
美股速递 · 05-27
Jupiter Neurosciences宣布帕金森病二期a阶段Reset试验患者招募启动
加载更多
公司概况
公司名称:
Jupiter Neurosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Jupiter Neurosciences, Inc.于2016年1月在特拉华州注册成立。该公司是一家临床阶段的研究与开发公司,专注于利用其专有的白藜芦醇制剂JOTROL开发针对神经炎症的治疗方法。其主要治疗目标是帕金森病,计划进行IIa期临床试验,并推出了面向消费者的Nugevia产品线,专注于长寿与健康领域。
发行价格:
--
{"stockData":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":1.76,"timestamp":1794603600000,"preClose":1.86,"halted":0,"volume":12564,"hourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.76,"latestTime":"19:30 EST","volume":12,"amount":21.92,"timestamp":1794616203074,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.053763440860215096,"floatShares":1098700,"shares":1318500,"eps":-18.567553,"marketStatus":"未开盘","change":-0.1,"latestTime":"11-13 16:00:00 EST","open":1.86,"high":1.9,"low":1.76,"amount":23115.680658,"amplitude":0.075269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-18.567553,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":0,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":1.86,"preHourTrading":{"tag":"盘前","latestPrice":1.82,"preClose":1.86,"latestTime":"09:28 EST","volume":412,"amount":754.588712,"timestamp":1794580128986,"change":-0.04,"changeRate":-0.021505,"amplitude":0.107527},"postHourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.76,"latestTime":"19:30 EST","volume":12,"amount":21.92,"timestamp":1794616203074,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6642909319810008},"requestUrl":"/m/hq/s/JUNS","defaultTab":"news","newsList":[{"id":"2677111949","title":"灰度研报:5 大热门代币收益率为负,稀释危机显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2677111949","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677111949?lang=zh_cn&edition=full","pubTime":"2026-10-23 11:07","pubTimestamp":1792724820,"startTime":"0","endTime":"0","summary":"据 Woofun AI消息,Grayscale最新发布的加密资产估值报告颠覆了传统叙事逻辑,明确指出除比特币外的多数代币可通过现金流进行定价。在该机构基于持有者收益率(Holder Yield)与调整后盈利收 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261023/c681013125.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261023/c681013125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670410788","title":"海外机构调研股出炉,融资客加仓多只海外机构调研个股(名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670410788","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670410788?lang=zh_cn&edition=full","pubTime":"2026-09-25 13:21","pubTimestamp":1790313660,"startTime":"0","endTime":"0","summary":"多只海外机构调研股获杠杆资金青睐,近10日,沪电股份、普冉股份、杰瑞股份、比亚迪的融资净买入额居前,均超1亿元。最新海外机构调研股出炉。港股早盘缩量下跌港股三大股指今日(9月25日)集 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260925/c680282758.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260925/c680282758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["ICLN","TCOM","VTWG","513600","ORCS","ORCX","SIMS","BIDG","MHImain","ORCU","IGV","HSI","SORCLmain","OGIG","09618","KJD","SMOG","ORCL","82800","JD","BEZ","TDIV","OBDC","BEX","CNRG","ZAP","BIDU","HHImain","02833","DRGN","EGGY","BEC","BEG","VCLN","IBAT","BE","BIZD","JUNS","07500","83115","ORCZ","UPGR","MCHmain","KBDU","WATS","PBDC","07200","CTEC","HYDR","FRNW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105390024","title":"Jupiter Neurosciences (纳斯达克: JUNS) 签署最终协议,以最高1亿美元交易价值获得Ala-002美国独家权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1105390024","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105390024?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:14","pubTimestamp":1784632453,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences(纳斯达克股票代码:JUNS)已签署一项最终协议,获得在研药物Ala-002在美国的独家商业化权利。此项交易总价值最高可达1亿美元,标志着该公司在拓展其神经科学产品管线方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189143379","title":"Pharmala Biotech达成价值高达1亿美元协议,包含333万美元预付款及里程碑付款与特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1189143379","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189143379?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:02","pubTimestamp":1784631771,"startTime":"0","endTime":"0","summary":"Pharmala Biotech宣布达成一项潜在总价值高达1亿美元的授权协议。该交易结构包括333万美元的预付款,后续根据研发与商业化里程碑支付的款项,以及基于销售额的特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144839675","title":"Pharmala Biotech签署最终授权协议,授予Jupiter Neurosciences Ala-002在美国的独家权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1144839675","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144839675?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:01","pubTimestamp":1784631679,"startTime":"0","endTime":"0","summary":"Pharmala Biotech已正式签署一项最终授权协议。根据该协议,Jupiter Neurosciences将获得候选药物Ala-002在美国市场的独家开发与商业化权利。\n此举标志着Jupiter Neurosciences在其神经科学产品管线布局上迈出了关键一步。通过获得Ala-002的独家授权,该公司有望加强其在特定治疗领域的市场地位。协议的财务条款及具体细节未在本次公告中披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188736438","title":"SK Pharmteco宣布与孤儿药加速器达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1188736438","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188736438?lang=zh_cn&edition=full","pubTime":"2026-06-18 21:48","pubTimestamp":1781790533,"startTime":"0","endTime":"0","summary":"SK Inc旗下子公司SK Pharmteco宣布与孤儿药治疗加速器(Orphan Therapeutics Accelerator)建立战略合作关系,双方将共同致力于罕见病疗法的开发与生产。此次合作旨在整合双方在各自领域的专长,加速创新疗法的研发进程,以满足全球罕见病患者的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136782521","title":"Jupiter Neurosciences宣布帕金森病二期a阶段Reset试验患者招募启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1136782521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136782521?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:32","pubTimestamp":1779881576,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences宣布,其针对帕金森病的二期a阶段Reset试验已启动患者招募工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jupiterneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.2},{"period":"1month","weight":-0.4483},{"period":"3month","weight":-0.6641},{"period":"6month","weight":-0.9306},{"period":"1year","weight":-0.9821},{"period":"ytd","weight":-0.977}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jupiter Neurosciences, Inc.于2016年1月在特拉华州注册成立。该公司是一家临床阶段的研究与开发公司,专注于利用其专有的白藜芦醇制剂JOTROL开发针对神经炎症的治疗方法。其主要治疗目标是帕金森病,计划进行IIa期临床试验,并推出了面向消费者的Nugevia产品线,专注于长寿与健康领域。","exchange":"NASDAQ","name":"Jupiter Neurosciences","nameEN":"Jupiter Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jupiter Neurosciences(JUNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jupiter Neurosciences(JUNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jupiter Neurosciences,JUNS,Jupiter Neurosciences股票,Jupiter Neurosciences股票老虎,Jupiter Neurosciences股票老虎国际,Jupiter Neurosciences行情,Jupiter Neurosciences股票行情,Jupiter Neurosciences股价,Jupiter Neurosciences股市,Jupiter Neurosciences股票价格,Jupiter Neurosciences股票交易,Jupiter Neurosciences股票购买,Jupiter Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jupiter Neurosciences(JUNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jupiter Neurosciences(JUNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}